Outlook Therapeutics, Inc. (OTLK)

NASDAQ: OTLK · IEX Real-Time Price · USD

7.96

-0.15 (-1.85%)

At close: Jul 19, 2024, 4:00 PM

7.90

-0.06 (-0.75%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Outlook Therapeutics Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Year Ending	TTM	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	2018 - 2014
Revenue	0	0	0	0	0	8.15	Upgrade
Revenue Growth (YoY)	-	-	-	-	-	163.84%	Upgrade
Gross Profit	0	0	0	0	0	8.15	Upgrade
Selling, General & Admin	25.78	26.67	20.74	12.77	9.97	9.37	Upgrade
Research & Development	34.08	26.45	42.33	38.96	26.34	23.81	Upgrade
Other Operating Expenses	0	0	0	0	0.53	11.27	Upgrade
Operating Expenses	59.86	53.13	63.07	51.73	36.84	44.45	Upgrade
Operating Income	-59.86	-53.13	-63.07	-51.73	-36.84	-36.3	Upgrade
Interest Expense / Income	2.19	1.56	1.49	0.94	1.76	3.47	Upgrade
Other Expense / Income	97.07	4.29	1.49	0.5	-0.09	-1.83	Upgrade
Pretax Income	-159.13	-58.98	-66.05	-53.16	-38.51	-37.93	Upgrade
Income Tax	0	0	0	0	-3.27	-3.41	Upgrade
Net Income	-159.13	-58.98	-66.05	-53.16	-35.24	-34.52	Upgrade
Preferred Dividends	0	0	0	0	13.63	1.52	Upgrade
Net Income Common	-159.13	-58.98	-66.05	-53.16	-48.87	-36.04	Upgrade
Shares Outstanding (Basic)	14	13	11	8	4	1	Upgrade
Shares Outstanding (Diluted)	14	13	11	8	4	1	Upgrade
Shares Change	11.20%	17.96%	38.91%	110.43%	298.84%	268.84%	Upgrade
EPS (Basic)	-11.41	-4.80	-6.20	-7.00	-13.40	-39.60	Upgrade
EPS (Diluted)	-11.41	-4.80	-6.20	-7.00	-13.40	-39.60	Upgrade
Free Cash Flow	-58.26	-42.97	-56.67	-54.25	-31.79	-32.73	Upgrade
Free Cash Flow Per Share	-4.08	-3.44	-5.34	-7.11	-8.76	-35.98	Upgrade
Gross Margin	-	-	-	-	-	100.00%	Upgrade
Operating Margin	-	-	-	-	-	-445.60%	Upgrade
Profit Margin	-	-	-	-	-	-442.41%	Upgrade
Free Cash Flow Margin	-	-	-	-	-	-401.75%	Upgrade
EBITDA	-156.86	-57.38	-64.36	-51.96	-36.2	-31.11	Upgrade
EBITDA Margin	-	-	-	-	-	-381.85%	Upgrade
Depreciation & Amortization	0.08	0.04	0.2	0.26	0.55	3.36	Upgrade
EBIT	-156.94	-57.42	-64.56	-52.23	-36.75	-34.47	Upgrade
EBIT Margin	-	-	-	-	-	-423.12%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).